Yüklüyor......
Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents
Immune checkpoint inhibitors have emerged as a mainstay of melanoma therapy and are playing an increasingly important role in the treatment of other tumor types. The clinical benefit afforded by these treatments can be accompanied by a unique spectrum of adverse events, called immune-related adverse...
Kaydedildi:
| Yayımlandı: | Oncologist |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AlphaMed Press
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5061539/ https://ncbi.nlm.nih.gov/pubmed/27401894 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0055 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|